Compromised T Cell Immunity Links Increased Cutaneous Papillomavirus Activity to Squamous Cell Carcinoma Risk.

Johnson, Luke H; Son, Heehwa G; Ha, Dat Thinh; Strickley, John D; Joh, Joongho; Demehri, Shadmehr

Johnson, Luke H; Son, Heehwa G; Ha, Dat Thinh; Strickley, John D; Joh, Joongho; Demehri, Shadmehr.

Afiliación

Johnson LH; University of Louisville School of Medicine, Louisville, Kentucky, USA.
Son HG; Center for Cancer Immunology, Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Ha DT; Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Strickley JD; Department of Medicine, University of Louisville School of Medicine, Louisville, Kentucky, USA.
Joh J; Center for Cancer Immunology, Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Demehri S; Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.

JID Innov ; 3(2): 100163, 2023 Mar.

Article en En | MEDLINE | ID: mdl-36714811

Palabras clave

DMBA, 7,12-dimethylbenz[a]anthracene; HPV, human papillomavirus; MmuPV1, mouse papillomavirus type 1; UVB, ultraviolet B; ab, antibody; cSSC, cutaneous squamous cell carcinoma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Revista: JID Innov Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google